Mycotechnology and IFF join forces in Europe to create better food system
Mycotechnology, a company using mycelia, the roots of mushrooms, and IFF have formed a partnership…
November 29, 2022 - 2 minutes
Liza Laws
BioPharma Dynamics expands to provide more solutions for cell and gene therapy industry
BioPharma Dynamics have expanded their portfolio for the cell and gene therapy market to offer…
November 29, 2022 - 2 minutes
Aptamer opens new facilities to meet growing demand for Optimer technology
Aptamer Group developer of Optimer binders that enable development in the life sciences industry has…
November 28, 2022 - 2 minutes
Lyvgen and Bristol Myers Squibb commitment to transform cancer care
Lyvgen Biopharma announced yesterday that it has started a phase 2 trial of LVGN7409 plus…
November 28, 2022 - 3 minutes
Monkeypox stigma and racism set to end by renaming to mpox, WHO reports
The World Health Organisation (WHO) said today (November 28) it will begin using mpox, as…
November 28, 2022 - 4 minutes
STORM Therapeutics doses first patient with drug targeting solid tumors
STORM Therapeutics Ltd, announced today that the first patient in a phase 1 study had…
November 28, 2022 - 2 minutes
Licensing agreement signed for C4XD between C4X Discovery and AstraZeneca
C4X Discovery Holdings plc has signed an exclusive worldwide licensing agreement with AstraZeneca. It is worth…
November 28, 2022 - 3 minutes
BIA and Exopharm sign joint research agreement to develop integrated technology
Slovenian-based Sartorius BIA Separations (BIA), a bio-chromatography company, and Australia's Exopharm Ltd., a company working…
November 23, 2022 - 4 minutes
Significant therapeutic potential of OSE Immunotherapeutics’ CLEC-1 published
OSE Immunotherapeutics SA has announced the publication of data in the peer-reviewed journal Science Advances…
November 23, 2022 - 3 minutes
Khondrion’s mitochondrial diseases treatment producing positive results
Clinical-stage pharmaceutical company, Khondrion, discovering and developing therapies targeting primary mitochondrial diseases announced yesterday (November…
November 23, 2022 - 5 minutes
Chiesi marks start of Biotech Center of Excellence for the future of medicine in Parma
An impressive crowd gathered at Chiesi Pharmaceutical Group yesterday (November 21) to mark the much-anticipated…
November 23, 2022 - 5 minutes
First patients dosed with Infex Therapeutics’ RESP-X for chronic respiratory disease
A new anti-virulence therapy, RESP-X, treating Pseudomonas aeruginosa (Pa) infections in non-cystic fibrosis bronchiectasis (NCFB)…
November 23, 2022 - 3 minutes
